By Jean-Baptiste Doucet | April 2026 LBP Program Leader at Biose Industrie Most of my week looks like batch planning, client timelines, and coordinating between our teams and the developers […]
Classical methodologies and current limitations Switching from a liquid medium to sold agar plates in the early 1800s was a significant change for microbiology sciences. Operational standardisation of plate counting […]
As 2025 draws to a close, I would like to take a moment to reflect on the key events and trends shaping our industry — and how they position us […]
Introduction Working to scale microbial strains from the gut microbiome can be a challenging feat. Selecting the right culturing conditions requires extensive experience, the right equipment, and a finely tuned […]
One in two people will develop cancer in their lifetime. Given this startling fact, developing novel treatments to improve cancer survivability is vital.
Today, on the International Day of Women and Girls in Science 2024, we celebrate the importance of achieving gender equality at work and we recognize the role that women and girls play in science and technology.
In the first of my blog posts for the year, I thought I would reflect on 2023 for the microbiome field, and explore what the field’s future may hold.
Review by Claire Derlot Head of Programs for LBP Development & Manufacturing A few weeks back, Nadine, Richard, Adrien, and I had the pleasure of attending the Boston-based microbiome drug […]
Introduction South Korea has emerged as a leading hub for innovative microbiome research and development, with a thriving biopharmaceutical industry and cutting-edge research institutions. In this article, we will highlight […]
Last month, Microbiome Movement returned to Boston for its 8th Drug Development summit. With 2023’s multiple regulatory approvals for C. difficile microbiome treatments, the event set out to platform microbial-based […]